Addus HomeCare (ADUS) Expected to Announce Earnings on Monday

Addus HomeCare (NASDAQ:ADUS) is expected to post its quarterly earnings results after the market closes on Monday, February 24th. Analysts expect Addus HomeCare to post earnings of $1.35 per share and revenue of $291.04 million for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Addus HomeCare Stock Down 2.5 %

Shares of NASDAQ:ADUS opened at $109.23 on Friday. Addus HomeCare has a fifty-two week low of $85.94 and a fifty-two week high of $136.72. The firm has a 50-day simple moving average of $125.04 and a 200 day simple moving average of $126.77. The company has a market cap of $1.98 billion, a PE ratio of 25.00, a P/E/G ratio of 1.45 and a beta of 1.00.

Insider Buying and Selling

In other news, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the sale, the executive vice president now owns 10,217 shares in the company, valued at $1,236,257. The trade was a 18.05 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the sale, the chief executive officer now owns 141,897 shares of the company’s stock, valued at approximately $17,476,034.52. This represents a 8.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 39,750 shares of company stock worth $4,930,750 in the last quarter. 4.60% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of analysts have recently weighed in on ADUS shares. StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Friday, January 24th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $136.00 price target on shares of Addus HomeCare in a research note on Thursday, November 14th. Stephens upped their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. JMP Securities started coverage on shares of Addus HomeCare in a research note on Monday, December 16th. They issued an “outperform” rating and a $150.00 price target for the company. Finally, Macquarie reaffirmed an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a research note on Monday, November 4th. One analyst has rated the stock with a sell rating, eight have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $134.22.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.